Company Filing History:
Years Active: 2005-2006
Title: Sylvaine Lafont: Innovator in Pharmaceutical Chemistry
Introduction
Sylvaine Lafont is a prominent inventor based in Trevoux, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of crystalline forms of complex compounds. Her work has led to advancements in the treatment of bacterial infections.
Latest Patents
Sylvaine Lafont holds 2 patents related to her innovative research. Her latest patents include the crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid. This invention encompasses various crystalline forms characterized by powder X-ray diffraction patterns, along with processes for preparing these forms and pharmaceutical compositions for treating bacterial infections. Another patent involves the monohydrated form C of the same compound, detailing methods for its preparation and use in pharmaceutical compositions.
Career Highlights
Sylvaine Lafont has established herself as a key figure in her field through her innovative research and patent contributions. She works at Aventis Pharma S.A., where she continues to explore new avenues in pharmaceutical development. Her work is instrumental in enhancing the efficacy of treatments for bacterial infections.
Collaborations
Throughout her career, Sylvaine has collaborated with notable colleagues, including Jacques Bourget and Marc Antoine Perrin. These collaborations have further enriched her research and contributed to her success in the pharmaceutical industry.
Conclusion
Sylvaine Lafont's contributions to pharmaceutical chemistry exemplify her dedication to innovation and research. Her patents and collaborative efforts continue to impact the field positively.